Who wins when telehealth companies push weight loss drugs? #digitalhealth #healthtech #healthcaretechnology No one is forcing patients or clinicians to embrace these platforms.Īs the health tech ecosystem evolves, these issues deserve debate and attention - difficult but necessary conversations. They provide better access and patient experience often at a lower cost. The counterpoint is that telehealth and digital health companies are filling a void left by the traditional healthcare system. It's hardly revolutionary.Ī slew of digital health point solutions also creates more fragmentation and leaves traditional healthcare providers to deal with issues that might arise. ![]() Direct advertising quick and easy access to popular medications may help generate revenue and satisfy investors. As companies struggle to find profitability and sustainable business models, the mission becomes harder to uphold. Even more so in today's tougher digital health environment. The pressure to match lofty valuations and justify outsized funding rounds is immense. Many doctors and nurses are disillusioned by traditional care and view health tech, with its loft mission statements and visionary founders, as a way to drive change. "We're just tech" is an unfortunate cop out.Ĭlinicians often aren't employed by these companies but rather serve as an "affiliated network." This arrangement creates an uncomfortable situation where digital health companies leverage clinicians for their licenses and ability to prescribe medications while leaving them on an island. Instead, doctors, nurse practitioners, and other clinicians ultimately bare responsibility (and potentially liability) for treatment decisions. ![]() #digitalhealth #healthcare #health #healthcaretechnology #regulation #healthtech #digitalmedicine #fdaĪs HLTH approaches, this article raises important questions to consider about telehealth platforms and the pros and cons of care delivery by digital health companies.Īre these solutions merely software conduits connecting patients to physicians? In arguing such, these companies can skirt regulation by the FDA, FTC, and FCC. Use the code below to receive a $100 discount! ![]() (For those who aren't familiar with DiMe, it's one of the premier organizations leading the way in bringing digital health into the mainstream the right way.) It's a must for those wanting to gain a solid understanding of the regulatory landscape in digital health. Not only is the material presented in an interactive and easy to digest format, it also provides essential information for strengthening business strategy, differentiating a product/service, and building trust in today's digital health market. I was fortunate enough to have early access to the course and highly recommend it for anyone building in digital health. Such a strategy can help ensure that digital health products meet necessary regulatory requirements, are cleared for market access as quickly and safely as possible and are optimally positioned for reimbursement.Īlong those lines, the Digital Medicine Society (DiMe) has announced its latest Digital Medicine Academy offering - "Unlocking Regulatory Success for Digital Health Product Developers." ![]() In short, a good regulatory strategy is essential to a good business strategy. As digital health enters its new era, there will rightly be a shift in focus from outsized funding rounds and rapid growth to efficacy, evidence generation, outcomes, and solid business fundamentals.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |